Objective There is no standardized therapy for renal amyloidosis, which shows rapid progression and poor prognosis. Here, we used 
Introduction
Renal amyloidosis is occasionally detected in patients with severe proteinuria and nephrotic syndrome as the first presenting symptom. Several outcome studies have discussed the onset and progressive mechanisms of renal amyloidosis; however, detailed analyses of a large number of cases have not been undertaken (1) (2) (3) (4) .
The therapeutic options for renal amyloidosis have been discussed in many studies (5) (6) (7) (8) (9) (10) (11) (12) (13) 
Patients and Methods

Patients
We (14) and Ishitobi et al (15) 
Cluster analysis
The cluster analysis method allows for division of the sample into groups based on the relative quantitative value of certain parameters (17) ; each group then has characteristic parameters (18, 19 
Groups by cluster analysis
Performing cluster analysis using the total renal histological damage score and s-Cr levels enabled definition of three cluster groups (Table 2-1). The s-Cr level was higher in Group 3 than in Groups 1 or 2. When the renal histological damage grade was 3 to 4 points (average score, 3.6), cases were grouped into Group 2. Group 1 represented those patients with one or two points (average score, 1.4). The grade of histological damage differed significantly between Groups 1 and 2 (p<0.0001).
Clinicopathological and cardiac functional background of each cluster group
The clinical and histological backgrounds of each cluster group are described in 
Renal survival curve for each cluster group
The renal survival curve for each cluster group is shown in Fig. 2 
. The renal survival rates of Groups 2 and 3 were lower than that of Group 1 (p=0.0008). As indicated by these curves, the disease progressed slowly in Group 1 but rapidly in Groups 2 and 3.
Multivariate analysis of poor prognostic factors in each cluster
We entered various parameters into multivariate analysis to determine their prognostic significance ( 
Individual survival rate at the end of the study
The individual survival rate at the study endpoint is shown in Fig. 3 (20, 21) . In contrast, Bohle et al (3) (3) . In the present study, patients in Groups 2 and 3 progressed rapidly, whereas those in Group 1 progressed slowly, to renal death (Fig. 2) . The hazard ratio (24) .
Discussion
Some reports have claimed that renal failure or renal dysfunction in patients with AA amyloidosis is more frequent than in patients with AL amyloidosis
Hypertension is one of the risk factors for impediment in many internal organs, for example, the brain, heart, kidney, blood vessels, and the retina (25) (26) (27) (28) (29) (30) (31) . Several studies have discussed the role of hypertension as a renal prognostic factor (27) (28) (29) , while others (32, 33) (35) . In this regard, correction of hypotension is reported to be important for quality of life (36) . However, the question of whether or not hypotension is a renal prognostic factor should be investigated in the future.
The relationship between nephrotic syndrome and prognosis has been discussed previously (3, 37 Table 3) .
Only a few studies have investigated the individual survival rate (4, 38) . Renal amyloidosis is associated with increased mortality in hemodialysis patients (36, 39) and in patients with rheumatoid arthritis (40) . The 
